← All organizations
Highest phase reached
Phase 3
First clinical trial
Aug 1, 2010Last known activity
May 20, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (7 distinct, 4 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Recent trials (5)
- NCT07252453Lead sponsorN/AMay 20, 2025
- NCT07252453Sponsor investigatorN/AMay 20, 2025
- NCT02703363CollaboratorPhase 3Aug 1, 2016
- NCT02074319CollaboratorPhase 1Dec 1, 2013
- NCT01602029CollaboratorPhase 2Aug 1, 2010
Details
- Last known activity
- May 20, 2025